(Q44412255)

2 December 2017

Quantitation of intrinsic drug-metabolizing capacity in human liver biopsy specimens: Support for the intact-hepatocyte theory (English)

1 reference

https://api.crossref.org/works/10.1002/HEP.1840130315

25 October 2022

author name string

B. Meyer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1671846

25 October 2022

H. S. Luo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1671846

25 October 2022

M. Bargetzi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1671846

25 October 2022

E. L. Renner

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1671846

25 October 2022

G. A. Stalder

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1671846

25 October 2022

language of work or name

English

0 references

publication date

1 March 1991

1 reference

full work available at URL

2 December 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fhep.1840130315

1 reference

https://api.crossref.org/works/10.1002/HEP.1840130315

https://onlinelibrary.wiley.com/doi/full/10.1002/hep.1840130315

25 October 2022

1 reference

https://api.crossref.org/works/10.1002/HEP.1840130315

25 October 2022

1 reference

2 December 2017

13

1 reference

2 December 2017

3

1 reference

2 December 2017

475-481

1 reference

Commentary: a physiological approach to hepatic drug clearance

2 December 2017

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840130315

Statistical methods for assessing agreement between two methods of clinical measurement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840130315

Monooxygenase activity of human liver in microsomal fractions of needle biopsy specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840130315

Alterations in the disposition of differently cleared drugs in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840130315

Drug disposition and liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840130315

7 January 2021

Drug Administration in Hepatic Disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840130315

7 January 2021

Propranolol disposition in chronic liver disease: a physiological approach

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840130315

7 January 2021

Determinants of drug disposition in patients with cirrhosis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840130315

7 January 2021

Drugs as indicators of hepatic function.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840130315

7 January 2021

The molecular mechanisms of two common polymorphisms of drug oxidation--evidence for functional changes in cytochrome P-450 isozymes catalysing bufuralol and mephenytoin oxidation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840130315

7 January 2021

Characterization of the common genetic defect in humans deficient in debrisoquine metabolism

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840130315

7 January 2021

Lignocaine metabolite formation as a measure of pre-transplant liver function.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840130315

7 January 2021

A semiautomatic image analyzing system based on an APPLE II or IIe personal computer.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840130315

7 January 2021

High-performance liquid chromatographic assays for bufuralol 1'-hydroxylase, debrisoquine 4-hydroxylase, and dextromethorphan O-demethylase in microsomes and purified cytochrome P-450 isozymes of human liver

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840130315

7 January 2021

Lidocaine metabolism in human liver microsomes by cytochrome P450IIIA4.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840130315

7 January 2021

A simple, rapid, and sensitive DNA assay procedure

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840130315

7 January 2021

The evolution of changes in quantitative liver function tests in a rat model of biliary cirrhosis: correlation with morphometric measurement of hepatocyte mass

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840130315

7 January 2021

Drug metabolism in liver disease: Activity of hepatic microsomal metabolizing enzymes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840130315

7 January 2021

Monooxygenase enzyme activity in alcoholics with varying degrees of liver damage

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840130315

7 January 2021

Aminopyrine N-demethylation by rats with liver cirrhosis. Evidence for the intact cell hypothesis. A morphometric-functional study.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840130315

7 January 2021

Protein measurement with the Folin phenol reagent

17

1 reference

https://api.crossref.org/works/10.1002/HEP.1840130315

European Journal of Pharmacology

25 October 2022

22

4

65

Schoene

1972

1 reference

https://api.crossref.org/works/10.1002/HEP.1840130315

European Journal of Pharmacology

25 October 2022

24

20

39

Brodie

1981

1 reference

https://api.crossref.org/works/10.1002/HEP.1840130315

European Journal of Pharmacology

25 October 2022

26

17

267

Sotaniemi

1980

1 reference

https://api.crossref.org/works/10.1002/HEP.1840130315

25 October 2022

Identifiers

1 reference

2 December 2017

1 reference